In vitro infection and pathogenesis of Chlamydia pneumoniae in endovascular cells

American Heart Journal

Volumn 138, Issue 5 II, 1999, Pages

  Quinn, T C ^a   Gaydos, C A ^a  

^a ROSS 1159 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 1BETA; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; AORTA MEDIA; ATHEROMA; ATHEROSCLEROSIS; BACTERIAL GROWTH; CHLAMYDIASIS; CHLAMYDOPHILA PNEUMONIAE; CONFERENCE PAPER; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; MACROPHAGE; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL;

EID: 0032716556     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0002-8703(99)70287-5     Document Type: Conference Paper

References (27)

1. Alexander RW. Inflammation and coronary artery disease. N Engl J Med 1994;331:468-9.
2. Wick G, Schett G, Amberger A, et al. Is atherosclerosis an immunologically mediated disease? Immunology Today 1995;16:27-33.
3. Van der Wal AC, Becker AE, Van der Loos CM, et al. Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation 1994;89:34-44.
4. Jackson LA, Campbell LA, Kuo CC, et al. Isolation of Chlamydia pneumoniae from a carotid endarterectomy specimen. J Infect Dis 1997;176:292-5.
5. Saikku P, Leinonen M, Tenkanen L, et al. Chronic Chlamydia pneumoniae infection as a risk factor for coronary heart disease in the Helsinki Heart Study. Ann Intern Med 1992;116:273-8.
6. Saikku P, Leinonen M, Mattila K, et al. Serological evidence of an association of a novel chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet 1988;2:983-5.
7. Saikku P. Chlamydia pneumoniae infection as a risk factor in acute myocardial infarction. Eur Heart J 1993;14(suppl K):62-5.
8. Shor A, Kuo CC, Patton DL. Detection of Chlamydia pneumoniae in coronary arterial fatty streaks and atheromatous plaques. South African Med J 1992;82:158-61.
9. Campbell LA, O'Brien ER, Cappuccio AL, et al. Detection of Chlamydia pneumoniae TWAR in human coronary atherectomy tissues. J Infect Dis 1995;172:585-8.
10. Danesh J, Collins R, Peto R. Chronic infections and coronary heart disease: is there a link? Lancet 1997;350:430-6.
11. Boman J, Soderberg S, Forsberg J, et al. High prevalence of Chlamydia pneumoniae DNA in peripheral blood mononuclear cells in patients with cardiovascular disease and in middle-aged blood donors. J Infect Dis 1998;178:274-7.
12. Laitinen K, Alakarppa H, Laurila A, et al. Animal models for Chlamydia pneumoniae infection. Scand J Infect Dis 1997;104:S15-7.
13. Fong IW, Chiu B, Viira E, et al. Rabbit model for Chlamydia pneumoniae refection. J Clin Microbiol 1997;35:48-52.
14. Moazed TC, Kuo C, Grayston JT, et al. Evidence of systemic dissemination of Chlamydia pneumoniae via macrophages in the mouse. J Infect Dis 1998;177:1322-5.
15. Muhlestein JB, Anderson JL, Hammond EH, et al. Infection with C. pneumoniae accelerates the development ofatherosclerosis and treatment with azithromycin prevents it in a rabbit model. Circulation 1998;97:633-6.
16. Stephens R, Byrne G, Christiansen G, et al, editors. Chlamydia pneumoniae infection accelerates the progression of atherosclerosis in apolipoprotrein (APO-E) deficient mice. In 1998; 9th International Symposium of human chlamydial infection, 426-9.
17. Laitinen K, Laurila A, Pyhala L, et al. Chlamydia pneumoniae infection induces inflammatory changes in the aortas of rabbits. Infect Immun 1997;65:4832-5.
18. Moazed TC, Kuo C, Grayston JT, et al. Murine models of Chlamydia pneumoniae infection and atherosclerosis. J Infect Dis 1997;175:883-90.
19. Holland SM, Taylor HR, Gaydos CA, et al. Experimental infection with Chlamydia pneumoniae in nonhuman primates. Infect Immun 1990;58:593-7.
20. Jackson LA, Campbell LA, Schmidt RA, et al. Specificity of detection of Chlamydia pneumoniae in cardiovascular atheroma: evaluation of the innocent bystander hypothesis. Am J Pathol 1997;150:1785-90.
21. Gaydos CA, Summersgill JT, Sahney NN, et al. Replication of Chlamydia pneumoniae in vitro in human macrophages, endothelial cells, and aortic artery smooth muscle cells. Infect Immun 1996;64:1614-20.
22. Gaydos CA, Pham DG, Quinn TC. Chlamydia pneumoniae infections in macrophages and coronary artery endothelial cells. In: Stary A, editor. Proceedings of the 3rd Meeting of the European Society for Chlamydia Research. Bologna, Italy: Societa Editrice Esculapio, 1996. p. 223.
23. Gaydos C, Pham D, Bobo L, et al. Cytokine profile of Chlamydia pneumoniae infected U-937 macrophages. Obstet Gynecol 1996;4(Intern sympos immunopath chlamydial infections):195.
24. Gaydos C, Madico G, Crotchfelt K, et al. Cytokine responses induced by growth of chlamydia pneumoniae in U-937 macrophages and human coronary artery endothelial cells. 9th Internatonal symposium on human chlamydial infection, Napa, Calif 1998; [Abstract.]
25. Gaydos C, Pham D, Quinn T. Growth suppression of Chlamydia pneumoniae by interferon-g in U-937 macrophages and HEp-2 cells [abstract]. Ann Meet Am Soc Microbiol 1995;D-171:278.
26. Kalayoglu MV, Byrne GI. Induction of macrophage foam cell formation by Chlamydia pneumoniae. J Infect Dis 1998;177:725-9.
27. Kalayoglu MV, Byme GI. A Chlamydia pneumoniae component that induces macrophage foam cell formation is chlamydial lipopolysaccharide. Infect Immun 1998;66:5067-72.